Publication | Open Access
Sofosbuvir Based Regimens in the Treatment of Chronic Hepatitis C with Compensated Liver Cirrhosis in Community Care Setting
12
Citations
23
References
2018
Year
In the community care setting, Sofosbuvir based DAAs are safe, effective with high overall SVR, and well tolerated in patients with CHC patients with compensated liver cirrhosis.
| Year | Citations | |
|---|---|---|
Page 1
Page 1